Atea Pharmaceuticals (AVIR) Insider Trading & Ownership $3.16 +0.02 (+0.64%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Atea Pharmaceuticals (NASDAQ:AVIR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$537,929.91 Get AVIR Insider Trade Alerts Want to know when executives and insiders are buying or selling Atea Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address AVIR Insider Buying and Selling by Quarter Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Atea Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/19/2024Jean-Pierre SommadossiCEOSell1,841$4.00$7,364.00 9/17/2024Jean-Pierre SommadossiCEOSell33,941$4.05$137,461.05 6/20/2024Bruce PolskyDirectorSell17,544$3.49$61,228.56 6/5/2024Jean-Pierre SommadossiCEOSell1,006$4.00$4,024.00 2/1/2024Andrea CorcoranInsiderSell15,843$3.84$60,837.12 2/1/2024Jean-Pierre SommadossiCEOSell56,910$3.85$219,103.50 2/1/2024Wayne FosterCAOSell12,477$3.84$47,911.68 (Data available from 1/1/2013 forward) AVIR Insider Trading Activity - Frequently Asked Questions Who is on Atea Pharmaceuticals's Insider Roster? The list of insiders at Atea Pharmaceuticals includes Andrea Corcoran, Bruce Polsky, Franklin M Berger, Jean-Pierre Sommadossi, Polly A Murphy, and Wayne Foster. Learn more on insiders at AVIR. What percentage of Atea Pharmaceuticals stock is owned by insiders? 17.80% of Atea Pharmaceuticals stock is owned by insiders. Learn more on AVIR's insider holdings. Which Atea Pharmaceuticals insiders have been selling company stock? The following insiders have sold AVIR shares in the last 24 months: Andrea Corcoran ($60,837.12), Bruce Polsky ($61,228.56), Jean-Pierre Sommadossi ($367,952.55), and Wayne Foster ($47,911.68). How much insider selling is happening at Atea Pharmaceuticals? Insiders have sold a total of 139,562 Atea Pharmaceuticals shares in the last 24 months for a total of $537,929.91 sold. Atea Pharmaceuticals Key ExecutivesDr. Jean-Pierre Sommadossi Ph.D. (Age 68)Founder, Chairman, CEO & President Compensation: $1.04MMs. Andrea J. Corcoran J.D. (Age 62)CFO, Executive VP of Legal & Secretary Compensation: $712.48kMr. Wayne Foster CPA (Age 55)Executive VP of Finance & Chief Accounting Officer Compensation: $580.46kDr. Janet M. J. Hammond M.D. (Age 64)Ph.D., Chief Development Officer Compensation: $789.47kDr. Maria Arantxa Horga M.D. (Age 56)Chief Medical Officer Compensation: $679.58kMs. Jonae R. BarnesSenior Vice President of Investor Relations & Corporate CommunicationsMr. Ariyapadi N. KrishnarajVice President of MarketingMr. Adel Moussa Ph.D.Executive Vice President of ChemistryMr. Xiao-Jian Zhou Ph.D.Executive Vice President of Early Stage DevelopmentMr. John F. Vavricka (Age 61)Chief Commercial Officer Compensation: $581.11k More Insider Trading Tools from MarketBeat Related Companies Inovio Pharmaceuticals Insider Trades Avadel Pharmaceuticals Insider Trades Zymeworks Insider Trades Septerna Insider Trades Cogent Biosciences Insider Trades Bicara Therapeutics Insider Trades Bicycle Therapeutics Insider Trades Collegium Pharmaceutical Insider Trades Phibro Animal Health Insider Trades ArriVent BioPharma Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:AVIR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
